what is a glp-1 receptor agonist PDB-101: Molecule of the Month: Agonists “Weighing In” on GLP-1 Receptor
Description
This variability can directly influence the intended effects of premedication, including stable preoperative sedation, gastric acid suppression, and PONV prevention
Both show anti-inflammatory potential
In the interim analysis of a phase III study (REGENERATE trial) at 18 months, 931 NASH patients with stage 23 fibrosis were randomly assigned to placebo and showed significant fibrosis improvement without NASH deterioration
2) insulin resistance leading to decreased glucose uptake by peripheral tissues (i.e., muscle and adipose)
doi: 10.1007/s40257-024-00911-x
Wood, D
